Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19. (2020)

First Author: Bovijn J

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(20)30345-3

PubMed Identifier: 33015641

Publication URI: http://europepmc.org/abstract/MED/33015641

Type: Journal Article/Review

Volume: 2

Parent Publication: The Lancet. Rheumatology

Issue: 11

ISSN: 2665-9913